← Open Payments lookup

JULIE REMPE: Open Payments

NPI 1740234194 · YORK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$620 in 38 payments from 14 companies in 2025. Trend: 2023 $825 · 2024 $726 · 2025 $620

Food & beverage: $620
CompanyPaymentsAmount
ABBVIE INC.20$300
Novo Nordisk Inc3$52
Lilly USA, LLC3$44
KYOWA KIRIN, INC.2$37
Astellas Pharma US Inc1$34
VERTEX PHARMACEUTICALS INCORPORATED1$24
Otsuka America Pharmaceutical, Inc.1$22
E.R. Squibb & Sons, L.L.C.1$19
ACADIA Pharmaceuticals Inc1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16

Products named: UBRELVY, QULIPTA, VRAYLAR, MOUNJARO, CRYSVITA, Veozah, AVYCAZ, REXULTI.

Industry payments across NE — which companies pay providers there.